Full Text
Cost-Effectiveness of Rivaroxaban Within Subgroups for Atrial Fibrillation and Venous Thromboembolism in The Netherlands

Abstract

Authors

J Gout-Zwart A Sediq M van den Bosch MJ Postma

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×